Serum Endocan Level and the Severity of Coronary Artery Disease: A Pilot Study

Murat Kose1, Samim Emet2, Timur Selcuk Akpinar1

  • 1Department of Internal Medicine, Istanbul School of Medicine, Istanbul University, Istanbul, Turkey.

Angiology
|August 30, 2014
PubMed

Insights

Serum endocan levels are significantly elevated in patients with acute coronary syndrome (ACS), indicating its potential as a biomarker for endothelial dysfunction in this condition.

Area of Science:

  • Cardiology
  • Biomarkers
  • Endothelial Biology

Background:

  • Endothelial-specific molecule 1 (endocan) is a proteoglycan primarily expressed in endothelial cells.
  • Endothelial dysfunction plays a critical role in the pathophysiology of acute coronary syndrome (ACS).

Purpose of the Study:

  • To investigate the association between serum endocan levels and the presence and characteristics of ACS.
  • To evaluate endocan as a potential biomarker for endothelial pathology in ACS patients.

Main Methods:

  • A case-control study involving 53 patients with ACS and 30 healthy controls.
  • Serum endocan levels were measured and compared between groups.
  • Coronary artery disease severity was assessed using Gensini and SYNTAX scores.

Main Results:

  • Serum endocan levels were significantly higher in the ACS group compared to the control group (P = .014).
  • Diabetic patients with ACS exhibited higher serum endocan levels than non-diabetic ACS patients (P = .016).
  • No significant correlation was found between serum endocan levels and Gensini or SYNTAX scores.

Conclusions:

  • Serum endocan levels are significantly elevated in patients with ACS, suggesting its role as a marker of endothelial pathology.
  • Endocan may serve as a novel biomarker for identifying endothelial dysfunction in the context of ACS.
  • Further research is warranted to explore the clinical utility of endocan in ACS management.

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
750
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.8K
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
493
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
616
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
956
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
1.1K